• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Medtronic Ireland ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Medtronic Ireland ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Catalog Number ESBF2814C103E
Medical Device Problem Codes Leak/Splash (1354); Malposition of Device (2616)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 07/23/2026
Type of Reportable Event Serious Injury
Event or Problem Description
An endurant iis stent graft system was implanted during the endovascular treatment of a 71mm abdominal aortic aneurysm.It was reported that during the index procedure, evar was performed and, upon completion angiography, the device was found not to have been delivered to the intended location.The proximal edge of the graft was positioned approximately 6 mm distal to the left renal artery, and a type ia endoleak was identified.An aortic extension etcf2828c49e was placed in desired proximal position with no endoleak observed.Per the physician the cause is undetermined.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
Film evaluation summary: the reported inaccurate delivery and type ia endoleak cannot be confirmed based on the limited pre-implant images provided; therefore, the cause of these events cannot be determined.Procedural angiograms demonstrating stent graft deployment, as well as the reported endoleak, were not available for in vivo assessment of the stent graft.It is likely that deployment of the stent 6 mm below the left renal artery contributed to the type ia endoleak; although this cannot be confirmed.Review of the returned films did not identify any obvious characteristics, such as significant neck tortuosity, thrombus, or calcification, that may have contributed to the inaccurate positioning event and endoleak.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT IIS BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
Medtronic Ireland
parkmore business park west
galway
EI 
Manufacturer (Section G)
Medtronic Ireland
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
+353(091)708096
MDR Report Key50173737
Report Number9612164-2026-03990
Device Sequence Number9880100
Product Code MIH
UDI-Device Identifier00643169439979
UDI-Public(01)00643169439979(17)280521
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/07/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberESBF2814C103E
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/24/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/23/2026
Initial Report FDA Received Date08/07/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/22/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-